Evidence map›Paper›PMID 21132016›Full record

ArticleEMBO reports2011

Yox1 links MBF-dependent transcription to completion of DNA synthesis.

Blanca Gómez-Escoda, Tsvetomira Ivanova, Isabel A Calvo, Isabel Alves-Rodrigues, Elena Hidalgo, José Ayté

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. TheBiomolecules · 2021
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Control of cell cycle transcription during G1 and S phases.Nature reviews. Molecular cell biology · 2013
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Blanca Gómez-EscodaOxidative Stress and Cell Cycle Group, Universitat Pompeu Fabra, C/Doctor Aiguader 88, Barcelona 08003, Spain.
Tsvetomira Ivanova
Isabel A Calvo
Isabel Alves-Rodrigues
Elena Hidalgo
José Ayté
Pompeu Fabra University · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When DNA replication is challenged cells activate a DNA synthesis checkpoint, blocking cell cycle progression until they are able to overcome the replication defects. In fission yeast, Cds1 is the effector kinase of this checkpoint, inhibiting M-phase entry, stabilizing stalled replication forks and triggering transcriptional activation of S-phase genes. The molecular basis of this last effect is largely unknown. The Mlu1 binding factor (MBF) complex controls the transcription of S-phase genes. We purified novel interactors of the MBF complex and identified the repressor Yox1. When the DNA synthesis checkpoint is activated, Yox1 is phosphorylated, which abrogates its binding to MBF. MBF-dependent transcription therefore remains active until cells are able to overcome this challenge.

Indexed as

Cell Cycle ProteinsCheckpoint Kinase 2DNA, FungalHomeodomain ProteinsPhosphorylationProtein BindingProtein Serine-Threonine KinasesRepressor ProteinsSchizosaccharomycesSchizosaccharomyces pombe ProteinsS PhaseTranscription FactorsCds1 protein, S pombeCell Cycle ProteinsCheckpoint Kinase 2DNA, FungalDSC1 protein, S pombeHomeodomain ProteinsNrm1 protein, S pombeProtein Serine-Threonine KinasesRepressor ProteinsSchizosaccharomyces pombe ProteinsTranscription FactorsYox1 protein, S pombe

Identifiers

PMID21132016
PMCPMC3024126
OpenAlexW2143466643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.